Abbott
9
20M
8
0.11
2
0.11
2
- Areas of investment
Summary
In 1944 was created Abbott, which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Illinois City.
Among the most popular portfolio startups of the fund, we may highlight SetPoint Medical, Respicardia, Ovalis. Among the most popular fund investment industries, there are Therapeutics, Life Science. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.
The fund is constantly included in less than 2 investment rounds annually. This Abbott works on 0 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 6 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2009. The important activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Abbott, startups are often financed by Three Arch Partners, Polaris Partners, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, New Enterprise Associates, Latterell Venture Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Polaris Partners, Lilly Ventures.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.11
- Follow on index
- 0.11
- Investments by industry
- Health Care (7)
- Medical Device (6)
- Biotechnology (4)
- Predictive Analytics (1)
- Artificial Intelligence (1) Show 15 more
- Investments by region
-
- United States (8)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 52M
- Group Appearance index
- 0.78
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.55
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hydra Biosciences | 12 Jan 2004 | Biotechnology, Medical, Life Science | Early Stage Venture | 18M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.